Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1981 Oct;46(4):410–414. doi: 10.1136/hrt.46.4.410

Evaluation of suppressor immune regulatory function in idiopathic congestive cardiomyopathy and rheumatic heart disease.

J L Anderson, J H Greenwood, H Kawanishi
PMCID: PMC482669  PMID: 6457616

Abstract

Several diseases with autoimmune features have recently been shown to be characterised by defects in suppressor cell immune regulation. Aberrant immune mechanisms of primary importance have been sought but not yet demonstrated for idiopathic congestive cardiomyopathy and rheumatic heart disease. We tested whether defective immunoregulatory function might explain certain features of these diseases. Peripheral blood mononuclear cells from patients with both diseases showed normal proliferative responses in the mixed leucocyte reaction. Concanavalin A induced similar suppressor activity, quantified in mixed leucocyte reaction as a suppression index, among control subjects, patients with rheumatic heart disease, and patients with idiopathic congestive cardiomyopathy. Similarly, patient serum supported induction of suppressor activity in normal leucocytes equal to that of control serum. A chronic immunoregulatory defect thus does not appear necessary for the development of idiopathic congestive cardiomyopathy or rheumatic heart disease.

Full text

PDF
410

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Fowles R. E., Bieber C. P., Stinson E. B. Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet. 1978 Dec 2;2(8101):1174–1177. doi: 10.1016/s0140-6736(78)92156-6. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. L., Fowles R. E., Stinson E. B., Yuge C., Bieber C. P., Harrison D. C. Occurrence of circulating heart-reactive antibodies in a population of cardiac transplant recipients. Correlation with cardiac rejection and subsequent course. Circulation. 1979 Sep;60(3):629–637. doi: 10.1161/01.cir.60.3.629. [DOI] [PubMed] [Google Scholar]
  3. Cambridge G., MacArthur C. G., Waterson A. P., Goodwin J. F., Oakley C. M. Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J. 1979 Jun;41(6):692–696. doi: 10.1136/hrt.41.6.692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Das S. K., Callen J. P., Dodson V. N., Cassidy J. T. Immunoglobulin binding in cardiomyopathic hearts. Circulation. 1971 Oct;44(4):612–616. doi: 10.1161/01.cir.44.4.612. [DOI] [PubMed] [Google Scholar]
  5. Decker J. L., Steinberg A. D., Reinertsen J. L., Plotz P. H., Balow J. E., Klippel J. H. NIH conference. Systemic lupus erythematosus: evolving concepts. Ann Intern Med. 1979 Oct;91(4):587–604. doi: 10.7326/0003-4819-91-4-587. [DOI] [PubMed] [Google Scholar]
  6. Engle M. A., Zabriskie J. B., Senterfit L. B., Gay W. A., Jr, O'Loughlin J. E., Jr, Ehlers K. H. Viral illness and the postpericardiotomy syndrome. A prospective study in children. Circulation. 1980 Dec;62(6):1151–1158. doi: 10.1161/01.cir.62.6.1151. [DOI] [PubMed] [Google Scholar]
  7. Fowles R. E., Bieber C. P., Stinson E. B. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation. 1979 Mar;59(3):483–491. doi: 10.1161/01.cir.59.3.483. [DOI] [PubMed] [Google Scholar]
  8. Gupta S., Schwartz S. A., Good R. A. Subpopulations of human T lymphocytes. VII. Cellular basis of concanavalin A-induced T cell-mediated suppression of immunoglobulin production by B lymphocytes from normal humans. Cell Immunol. 1979 May;44(2):242–251. doi: 10.1016/0008-8749(79)90002-9. [DOI] [PubMed] [Google Scholar]
  9. Hodgson H. J., Wands J. R., Isselbacher K. J. Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1549–1553. doi: 10.1073/pnas.75.3.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jacobs B., Matsuda Y., Deodhar S., Shirey E. Cell-mediated cytotoxicity to cardiac cells of lymphocytes from patients with primary myocardial disease. Am J Clin Pathol. 1979 Jul;72(1):1–4. doi: 10.1093/ajcp/72.1.1. [DOI] [PubMed] [Google Scholar]
  11. Kawai C., Takatsu T. Clinical and experimental studies on cardiomyopathy. N Engl J Med. 1975 Sep 18;293(12):592–597. doi: 10.1056/NEJM197509182931207. [DOI] [PubMed] [Google Scholar]
  12. Kirsner A. B., Hess E. V., Fowler N. O. Immunologic findings in idiopathic cardiomyopathy: a prospective serial study. Am Heart J. 1973 Nov;86(5):625–630. doi: 10.1016/0002-8703(73)90339-6. [DOI] [PubMed] [Google Scholar]
  13. Kishimoto S., Tomino S., Mitsuya H., Fujiwara H. Age-related changes in suppressor functions of human T cells. J Immunol. 1979 Oct;123(4):1586–1593. [PubMed] [Google Scholar]
  14. Lessof M. Immunological reactions in heart disease. Br Heart J. 1978 Mar;40(3):211–214. doi: 10.1136/hrt.40.3.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miller K. B., Schwartz R. S. Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med. 1979 Oct 11;301(15):803–809. doi: 10.1056/NEJM197910113011502. [DOI] [PubMed] [Google Scholar]
  16. Read S. E., Fischetti V. A., Utermohlen V., Falk R. E., Zabriskie J. B. Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever. J Clin Invest. 1974 Aug;54(2):439–450. doi: 10.1172/JCI107780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Reinherz E. L., Rubinstein A., Geha R. S., Strelkauskas A. J., Rosen F. S., Schlossman S. F. Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med. 1979 Nov 8;301(19):1018–1022. doi: 10.1056/NEJM197911083011902. [DOI] [PubMed] [Google Scholar]
  18. Reinherz E. L., Schlossman S. F. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14;303(7):370–373. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
  19. Reinherz E. L., Weiner H. L., Hauser S. L., Cohen J. A., Distaso J. A., Schlossman S. F. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med. 1980 Jul 17;303(3):125–129. doi: 10.1056/NEJM198007173030303. [DOI] [PubMed] [Google Scholar]
  20. Shore A., Limatibul S., Dosch H. M., Gelfand E. W. Identification of two serum components regulating the expression of T-lymphocyte function in childhood myasthenia gravis. N Engl J Med. 1979 Sep 20;301(12):625–629. doi: 10.1056/NEJM197909203011202. [DOI] [PubMed] [Google Scholar]
  21. Shou L., Schwartz S. A., Good R. A. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med. 1976 May 1;143(5):1100–1110. doi: 10.1084/jem.143.5.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Twomey J. J., Laughter A. H., Steinberg A. D. A serum inhibitor of immune regulation in patients with systemic lupus erythematosus. J Clin Invest. 1978 Sep;62(3):713–715. doi: 10.1172/JCI109180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Waldmann T. A., Blaese R. M., Broder S., Krakauer R. S. Disorders of suppressor immunoregulatory cells in the pathogenesis of immunodeficiency and autoimmunity. Ann Intern Med. 1978 Feb;88(2):226–238. doi: 10.7326/0003-4819-88-2-226. [DOI] [PubMed] [Google Scholar]
  24. Wong C. Y., Woodruff J. J., Woodruff J. F. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1. J Immunol. 1977 Apr;118(4):1165–1169. [PubMed] [Google Scholar]
  25. Yang L. C., Soprey P. R., Wittner M. K., Fox E. N. Streptococcal-induced cell-mediated-immune destruction of cardiac myofibers in vitro. J Exp Med. 1977 Aug 1;146(2):344–360. doi: 10.1084/jem.146.2.344. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES